Cantor raises Instacart stock price target on steady growth outlook By Investing.com

Instacart reported Q1 results roughly in line on GTV and EBITDA, with EBITDA about 4% above prior Street estimates and EPS of $0.57 versus $0.39 consensus. Cantor Fitzgerald raised its price target to $54 from $52 and kept an Overweight rating, citing 11% to 13% Q2 GTV growth guidance, 73.7% gross profit margin, and progress in enterprise, ads, and AI initiatives. Shares were down about 8% intraday despite the constructive outlook, reflecting investor focus on lower GTV upside and smaller incremental margin than in prior quarters.

Analysis

CART is turning into a “quality growth” story rather than a pure delivery multiple story: the key signal is that monetization is expanding even while order growth is not perfectly linear. That matters because the market has been willing to pay for software-like margin durability only when the business shows it can keep extracting more value per transaction; a 73%+ gross margin profile plus ad/enterprise attach rate improves the odds that EBITDA revisions keep outpacing revenue revisions over the next 2-3 quarters.

The second-order dynamic is competitive. If Instacart can sustain double-digit transaction growth with only modest margin pressure, smaller delivery platforms and local grocery tech vendors lose pricing leverage, especially those without a retail media layer or enterprise tooling. The real moat is not delivery density; it is checkout ownership, audience data, and ad monetization, which can force grocers into a choice between paying up for access or accepting lower digital traffic quality.

The near-term risk is that the market is extrapolating peak efficiency from a quarter that likely benefited from basket mix and easier comps. If order growth remains sub-10% while investors were expecting reacceleration, the stock can de-rate quickly because the multiple is already implicitly underwriting continued expansion into 2026. The catalyst path is straightforward: another clean quarter with ad and enterprise contribution can re-rate the name, while any evidence that margin expansion is flattening or guidance proves conservative on gross transaction value will hit the stock hard within days.

The contrarian read is that the selloff may be overdone relative to the fundamental signal: guidance with low-teens transaction growth and only slight margin expansion is not a deterioration, it is normalization after a stronger margin phase. At roughly 7x forward EBITDA, the market is pricing CART like a mature marketplace rather than a platform with multiple incremental monetization levers. That asymmetry favors owning dips rather than chasing strength, provided the business keeps compounding ad load and enterprise penetration.

Key Decisions for Investors

• Buy CART on weakness into the next 2-5 trading sessions; target a rebound toward prior highs if the market refocuses on guidance durability and monetization mix. Risk/reward: ~2:1 if downside is capped by cash-rich balance sheet and upside comes from multiple expansion back to peer SaaS/marketplace levels.
• Sell downside puts in CART 1-2 months out at strikes ~10-15% below spot if liquidity is adequate; collect elevated volatility while expressing a view that the post-earnings drawdown was larger than the fundamental miss. Risk: reassess if next guidance update shows transaction growth decelerating below low double digits.
• Pair trade: long CART / short a lower-quality delivery or marketplace proxy with weaker ad economics and balance sheet flexibility over the next quarter. The trade isolates monetization durability versus pure volume exposure; it should work if investors continue rewarding platform mix over headline order growth.
• For more tactical traders, buy CART call spreads 1-3 months out to express a mean-reversion view without paying full premium for an outright re-rating. Best entry is after volatility compresses from the earnings event.
• Add NDAQ only as a comparison basket hedge, not an alpha long: if the market broadens into quality-growth software/platform names, CART should have higher beta to the factor. Keep NDAQ exposure neutral if you want to avoid diluting the thesis.